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Introduction
The mitotic phase of cell division relies on assembly of the mitotic spindle. Microtubules are the main constituent of the mitotic spindle and are composed of the α-β heterodimeric protein tubulin. 1 They are highly dynamic structures that alternate between periods of growing and shrinking through the addition or removal of tubulin subunits at the ends of microtubules. 2 Microtubules are a highly-validated target in cancer therapy and a large number of chemically diverse substances bind to tubulin and alter microtubule polymerization and dynamics in diverse ways. 3 These ligands can be broadly divided into two categories: those that inhibit the formation of the mitotic spindle, e.g. colchicine (1, Figure 1 ) and the vinca alkaloids, and those that inhibit the disassembly of the mitotic spindle once it has formed, e.g.
paclitaxel and epothilone. 4 Tubulin-binding compounds, such as paclitaxel and vinblastine, are in widespread clinical use for various types of cancer. 3 The combretastatins are a group of tubulin-binding diaryl stilbenes isolated from the stem wood of the South African tree Combretum Caffrum. 5 There is no written evidence of use of the plant for treating cancer amongst the indigenous people of Africa. 6 A number of constituent stilbenes were found to inhibit the growth of colon cancer cells and were strong inhibitors of tubulin polymerisation. 5 Combretastatin A-4 (2a, Figure 1 ) and combretastatin A-1 (2b, Figure 1 ) exhibited potent anticancer activity against a panel of human cancer cell lines from diverse origins, including leukaemic, breast and multi-drug resistant cancers. 4 Stilbenes 2a and 2b inhibit the formation of the mitotic spindle by binding to the colchicine-binding site of tubulin and were also shown to exhibit anti-vascular properties in vivo, probably by increasing tumor-vessel permeability. 7, 8 However, 2a and 2b display poor water solubility rendering them unsuitable for clinical use and water-soluble prodrugs, including combretastatin A-4phosphate (2c, Figure 1 ), are in clinical trials, for example evaluation of 2c for advanced anaplastic thyroid cancer and in combination with chemotherapy for advanced solid tumours. [9] [10] [11] 2c displays excellent water solubility, good stability and cell growth inhibitory activity comparable to that of 2a. 11 However, the biological activity of 2a is lost if isomerization to the inactive trans form occurs, for example during storage. 12, 13 Many conformationally restricted analogues of 2a are known, in which the cis double bond is replaced by a heterocycle, thereby locking the two aryl rings in a cis-like configuration relative to each other. A diverse range of heterocycles as replacements for the double bond have been reported including benzoxepins, 14 oxadiazolines, 15 imidazoles, 16 combretoxazolones, 17 combretocyclopentenones 13 and thiophenes, 18 and are the subject of many reviews. 4, 12, 19 Previously, βlactam containing compounds were reported to have anticancer activity 20, 21 and the β-lactam ring scaffold has been investigated as a template for analogues of 2a. [22] [23] [24] We have recently reported a series of antiproliferative, tubulin-binding β-lactam compounds, where 3a, 3b and 3c (Figure 1 ) emerged as the most potent agents with activity comparable to 2a. 24 A 3-phenyl ring substituent improved the potency of this series of β-lactam compounds compared to either 3-methyl or 3,3-dimethyl substitution or β-lactams unsubstituted at C-3. β-Lactam 3b was shown to induce rapid apoptosis in vitro in leukaemic HL-60 cells and also induced apoptosis in ex vivo samples from patients with chronic myeloid leukaemia, including those positive for the T315I mutation displaying resistance to imatinib mesylate and dasatinib. 25 Due to the potency of the 3-phenyl substituted compounds 3a and 3b, a series of novel analogues with diverse carbocycles and heterocycles to replace the phenyl ring were developed and evaluated for their antiproliferative activity and tubulin effects. These novel compounds reported herein contain carbocyclic, heterocyclic or modified aryl substituents at position 3 of the β-lactam ring while the aryl rings A and B present in 2a are retained at positions 1 and 4 of the azetidinone scaffold.
The rigid β-lactam ring structure facilitates a similar spatial arrangement between the two aryl rings at N-1 and C-4 as is observed for the cis configuration of 2a.
Insert Figure 1 2. Results and Discussion
Chemistry
The synthetic routes for target β-lactam preparation are illustrated in Schemes 1 -6. The compounds chosen for initial investigation all contained the 3,4,5-trimethoxyphenyl (mimicking ring A of 2a) as the β-lactam N-1 substituent, together with the 4-methoxyphenyl ring as the β-lactam C-4 substituent. Two routes for the β-lactam ring-forming reaction were employed. The Staudinger reaction requires appropriately substituted acetic acids or acid chlorides and imines 26 (Scheme 3; Routes I, II and III), while the Reformatsky reaction requires an organozinc species (derived from an α-bromoester) and an imine (Scheme 6). 27 In two cases, the desired acetic acid precursors for β-lactam preparation were not commercially available. To prepare selected 2-thienyl containing derivatives, the appropriately substituted 2-thienyl aldehydes were converted to the corresponding acetic acids through the use of tetraethyl dimethylaminomethylenediphosphonate (4, Scheme 1). 28 It was previously reported that the most convenient and efficient method to produce this aminodiphosphonate reagent was the reaction of dimethylchloroformiminium chloride with 2.2 equivalents of triethyl phosphite. 29 The in-situ generated iminium ion reacts with triethyl phosphite to generate 4 in high yields of up to 76% (Scheme 1). This reagent reacts with the aldehyde of interest to form an enamine phosphonate, which is hydrolysed with strong acid to produce the substituted acetic acids 5a and 5b (Scheme 1).
Substituted acetic acids were required in the Staudinger reaction for the preparation of β-lactams in two procedures. Firstly, the acid chloride could be generated from the acid for use in a traditional Staudinger reaction. Alternatively, direct preparation of β-lactams from substituted acetic acids by the Staudinger route using an acid-activating agent is possible (see below). In the first option, generation of the acid chloride (6a, 6b) from the corresponding substituted acetic acid was achieved by chlorination with thionyl chloride. The chlorination reactions were monitored by IR until absorption was observed between ν 1780 cm -1 and ν 1815 cm -1 , due to carbonyl stretching in the acid chloride. Acid chlorides 6a
and 6b were synthesised in high yield and were immediately used in the following β-lactam forming reaction without further purification (Scheme 3).
The preparation of imine precursors 8a -8f is achieved in high yield by condensation of the appropriately substituted aldehydes and anilines (Scheme 2). 30 In the case of 3-hydroxy-4methoxybenzaldehyde, the hydroxyl group was first protected using the TBDMS silyl ether group and then used for the preparation of Schiff base 8b. 31 The preparation of target β-lactams 10 -27 is illustrated in Scheme 3. β-Lactam synthesis was primarily carried out using the Staudinger reaction, which is a cycloaddition reaction between a ketene and an imine under basic conditions, where the ketene can be generated from an acid chloride. 32 β-Lactams 10 -18 were prepared by this method (Scheme 3, route I). A modified procedure for preparation of the 3-thienyl compound 19 was employed, as the standard Staudinger reaction conditions were unsuccessful. β-Lactam 19 was obtained in 48% yield using milder conditions with overnight stirring at room temperature (Scheme 3, route II). 33 The stereochemistry of products from the Staudinger reaction depends on numerous factors, including the reaction conditions, the order of addition of the reagents and the substituents present on both the imine and on the acid chloride. 20, 32, 34 The trans products were isolated exclusively in all but one case, as evident from the representative 1 H NMR spectrum of compound 13 where the H-3 and H-4 were identified at δ 4.47 ppm and δ 4.90 ppm respectively as a pair of coupled doublets, J3,4 = 2.5 Hz. The formation of the trans isomer is likely due to steric hindrance when two aryl rings present in the β-lactam structure at C-3 and C-4. The sole exception in this series of compounds was the 3-methyl-3-phenyl substituted β-lactam 11, which was obtained as a mixture of cis/trans isomers (ratio 1:1.13 cis:trans) and separated by crystallization from ethanol. The presence of structural isomers was confirmed by X-ray crystal structures of both isomers of 11 ( Figure 2 ). Both enantiomers of 11 can be seen in the crystal structure of the trans isomer ( Figure   2b ). The X-ray crystal structure of 3,3-diphenyl β-lactam 12 is illustrated in Figure 3 .
Insert Figures 2 and 3
The β-lactam ring scaffold could also be generated directly from the appropriately substituted acetic acid and imine precursors using an acid-activating agent in a one-step reaction, without generation and isolation of the acid chloride (Scheme 3, route III). Many acid-activating agents are known in literature, e.g. Mukaiyama's reagent, p-toluene-sulfonyl chloride and various phosphorous derived reagents. 32 Triphosgene has been reported for the synthesis of β-lactams and was employed as an acid-activating agent in synthesis of compounds 20 -27. 35, 36 The phenolic products 28 and 29 were obtained on treatment of the silyl ethers 14 and 27 respectively with tetrabutylammonium fluoride at 0 ˚C (Scheme 4). 31 Separation of the silylated β-lactams 14 and 27
from the silylated imine in the final reaction mixture was difficult and hence removal of the silyl protecting group was carried out before subsequent purification. Reduction of the nitro group in compound 19 to the corresponding amine 30 was achieved by treatment with zinc dust and glacial acetic acid (Scheme 5). 37 Preliminary biochemical assessments of β-lactams 10 -30 in MCF-7 human breast cancer cells revealed potent antiproliferative activity for thiophene containing compounds 13, 24, 28, 29 and 30
( Table 2 ). On the basis of these results, further sulfur-containing β-lactam analogues were prepared. 3-Unsubstituted β-lactam 9 was used as a precursor for a variety of substitution reactions at C-3.
Compound 9 was obtained by Reformatsky reaction of imine 8a with ethylbromoacetate and zinc using microwave technology and TMCS as the zinc-activating agent as we have previously reported. 24, 27 Deprotonation of 9 with LDA at -78 °C followed by reaction with aldehydes 32, 38 All β-lactam compounds 10 -27 were obtained as enantiomeric mixtures and separation by chiral liquid chromatography was demonstrated for selected compounds 13 and 33, indicating a 1:1 mixture of the two enantiomers for both compounds (Figure 10 , Supplementary Information). We have previously demonstrated stability of 3-phenyl β-lactams over the pH range 4 -9. 24 Preliminary stability studies of 3-(2-thienyl) β-lactams with aryl, naphthyl and thienyl substituents at C-4 (compounds 13, 16, 17 and 18) were carried out in acidic, neutral and basic pH conditions. The half-lives for these compounds were determined to be greater than 24 hours at pH values of 4, 7.4 and 9, with the compounds being least stable at pH 4 for all four analogues assessed.
Biological Results and Discussion

Antiproliferative effects
The series of β-lactam analogues of 2a were initially evaluated for their antiproliferative activity in human MCF-7 breast cancer cells using the MTT cell viability assay. 40 The previously reported lead compound, 3a, showed potent activity in this cancer cell line with an IC50 of 0.034 μM and further investigation established 3a and 3b as potential lead development candidates for the treatment of leukaemia. 24, 25 To establish a more detailed SAR and further examine the effects of 3-substitution on antiproliferative activity, the phenyl ring at the 3-position of 3a was replaced with a wide variety of carbocyclic and heterocyclic substituents, while retaining the N-1, C-4 substituents of 3a (Table 1) .
The most potent β-lactams in MCF-7 cells were those with 3-(2-thienyl) (13) and 3-(3-thienyl) (24) substituents with IC50 values of 64 nM and 60 nM respectively. Replacement of the sulfur atom of 24
with oxygen (furan analogue 23) led to a two-fold decrease in activity. Introduction of multiple and/or larger substituents at this position led to substantial decrease in activity compared to substitution with a phenyl ring, for example diphenyl 12 (IC50 of 43.17 μM), 1-naphthyl 20 (11.32 μM), 2-naphthyl 21
(2.47 μM) and methyl indole 22 (6.59 μM). The bulky benzothiophene analogue 26 has a much greater IC50 value of 0.85 μM than the corresponding thiophene derivative 13 (IC50 value of 0.064 μM). This is in line with previous observations that poly-substitution of the C-3 phenyl ring led to decreased activity. 24 A cyclohexane ring at position 3 of the β-lactam (10) showed decreased activity of over 100-fold compared to the 3-phenyl substituted compound 3a. Cyclohexane-substituted 10 has a higher cLogP value of 4.87 compared to 3.88 for 3a, indicating a marked increase in hydrophobicity. It is possible that this property contributes to its relative lack of antiproliferative activity. Disubstitution at the 3-position yielded the two compounds with the least antiproliferative activity in MCF-7 cells, 3-methyl-3-phenyl substituted 11 (IC50 of 43.45 μM; evaluated as a mixture of cis/trans isomers) and 3,3-diphenyl substituted 12 (IC50 of 43.17 μM). From these results, it can be deduced that substituents larger than a phenyl ring at the 3-position are detrimental to the antiproliferative activity of this series of compounds. 
Insert Figure 4
The effect of introduction of a carbon spacing atom between the thiophene ring and C-3 of the β- nM) and showed improved activity compared to the lead compound 3a (IC50 = 78 nM) ( Table 3 ). . The anti-proliferative activity of 13 was particularly potent for all three leukaemic cell lines (<10 nM) and for CNS, melanoma and breast cell lines, indicating a wide-range of potential therapeutic applications. The mean LC50 for 13 across the range of cell lines is >100 μM indicating minimal cytotoxicity. In addition, matrix COMPARE analysis 42, 43 (measuring the correlation between two compounds with respect to their differential antiproliferative activity) demonstrated good correlation between 13, 3b and 2a (r=0.76 and 0.61 respectively). However, this algorithm does not distinguish between different tubulin-based mechanisms of action. 44 The COMPARE algorithm was also used to compare the differential antiproliferative activities of 13 to compounds with known mechanisms of action in the NCI Standard Agent Database 4 and showed correlations to vincristine, paclitaxel, maytansine and rhizoxin, all of which affect microtubule polymerization ( Table 4 ).
Further
Evaluation of toxicity in normal murine mammary epithelial cells
Further toxicity measurements were carried out on 3-(2-thienyl) β-lactam 28, the most potent antiproliferative β-lactam in antiproliferative assessment with MCF-7 cells. Toxicity studies in healthy mouse mammary epithelial cells at two different cell concentrations were carried out (25,000 cells/mL and 50,000 cells/mL harvested from mid-to late-pregnant CD-1 mice and cultured as described previously 45, 46 ). These results indicate a favorable toxicity profile for 28 in comparison to 2a. The IC50 value for both compounds was greater than 10 μM indicating minimal toxicity for this compound ( Figure 5 ) (Table 7 and Figure 12 , Supplementary Information). Tubulin polymerization studies on 28 showed a 3.2-fold reduction in the Vmax at 10 μM compared to a 6-fold reduction for 2a tested as a control. The IC50 value for 28 for the inhibition of Vmax was calculated to be 1.37 ± 0.85 μM, while an IC50 value of 6.25 ± 2.53 μM was obtained for the effect in overall polymer mass (calculated from area under the polymerization curve) ( Figure 6 ). This confirms that the molecular target of these antiproliferative β-lactams is tubulin.
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Structural Studies, Molecular Modeling and Rationalization of Biochemical Activity
Based on the 3D structural similarity between the ligands 1, 2a and the β-lactam analogues reported in this study, we propose that the binding site for these compounds is most likely to be the colchicine site, as it has been demonstrated that 2a and many reported examples of the structurally related conformationally constrained 2a analogues bind at the colchicine site. [47] [48] [49] The colchicine-binding site in tubulin is mainly buried in the β-subunit of tubulin, whilst maintaining some limited interactions with the α-subunit. The H7 and H8 α-helices, the T7 loop and the S8 and S9 β-strands contribute to the binding site and interact with the colchicine-site ligand. 50 Two of the most important residues for colchicine-binding are Val318 and Cys241. Val318 tubulin variants have reduced sensitivity to 1, and 1 substituted with more reactive groups instead of the methoxys can be crosslinked with Cys241. 51, 52 The Thr179 residue has also been highlighted as being important, though not critical, for binding. 53 Previously reported β-lactams 3a and 3b both show interactions with Val318 and Cys241, while 3b has an additional hydrogen-bonding interaction with Thr179. 24 The antiproliferative assessment of the β-lactam compounds 10 -38 (Table 2) in the X-ray crystal structures of these analogues is -61.7 ° for compound 12 (Figure 3 ). For compound 11, a dihedral angle of 73.4 ° is observed for the cis isomer while values of 62.7 ° and -66.1 ° are calculated for the two enantiomers of the trans isomer ( Figure 2 ). These values are very different to the dihedral angle previously observed for 3a of 46.9 °, 24 and are also higher than the values for 1 (55 °) 51 and 2a (53 °) 54 . It is possible that this difference in orientation between the two rings is one of the 
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In contrast to 3,3-diphenyl β-lactam 12, virtual molecular docking of the most potent β-lactam from this series, 3-(2-thienyl) β-lactam 28, predicts a docked conformation similar to that previously predicted for 3b ( Figure 8 , also figure 11 in supplementary information). 24 The dihedral angle between the N-1 and C-4 phenyl rings of 28, calculated from the energy minimized structure rather than a crystal structure, is 61.8°. The predicted 2D interactions of the ligand with the protein are shown in figure 9. 55 Residues Cys241 and Val318 interact with the trimethoxyphenyl ring of 28. Hydrogen bonding of the phenolic group of ring B to Thr179 and Lys352 contributes to the strong tubulin binding of this compound observed in vitro and is suggested to account for the increased antiproliferative activity seen with the phenolic compounds 28 and 29. Further hydrophobic interactions between the 3-(2-thienyl) ring and the colchicine site residues (Figure 9 ) reinforce the binding to the protein, for example with Val181, Leu248 and Ala250. These interactions, in contrast to those of β-lactam 12, may stabilize the binding of 28 and provide a rational basis for the potent antiproliferativea nd tubulin-binding activity displayed by these compounds.
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Summary and conclusion
Building on previous work where the β-lactam ring scaffold was utilized to replace the isomerisable double-bond of 2a, further investigations to determine a comprehensive SAR of antiproliferative βlactams has led to the new discovery of novel analogues with significant antiproliferative and tubulinbinding activity. A trend for small ring heterocyclic systems at the 3-position ring leading to increased potency was determined, with larger ring systems such as naphthyl, indole and benzothiophene leading to significantly less potent anti-proliferative activities. 3-(2-Thienyl) and 3-(3-thienyl) derivatives 28 and 29 displayed the most potent antiproliferative activity in MCF-7 and MDA-MB-231 breast cancer cell lines with low nanomolar antiproliferative IC50 values, and 28 was shown to be minimally toxic to normal murine epithelial cells. The molecular target of β-lactam 28 was confirmed to be tubulin, and this compound displayed an IC50 value of 1.37 μM for inhibition of tubulin polymerization. The 2thienyl and 3-thienyl containing compounds reported herein will be evaluated in further in vitro and in vivo studies to develop their potential vascular targeting and antiangiogenic applications.
Experimental Section
Chemistry: Experimental Methods
All reagents were commercially available and were used without further purification unless otherwise indicated. Tetrahydrofuran (THF) was distilled immediately prior to use from Na/Benzophenone under a slight positive pressure of nitrogen, toluene was dried by distillation from sodium and stored on activated molecular sieves (4 Å) and dichloromethane was dried by distillation from calcium hydride prior to use. IR spectra were recorded as thin films on NaCl plates or as KBr discs on a Perkin-Elmer 
General method for chlorination of acetic acid derivatives:
The appropriate acetic acid (10 mmol) was brought to reflux with thionyl chloride (12 mmol) in chloroform (30 mL). The reaction was monitored by I.R. until absorption appeared between 1780cm -1 and 1815cm -1 . The solvent was evaporated under reduced pressure. 57 was prepared from phenylpropionic acid in 92.2% yield as a pale yellow oil and was used immediately in the subsequent reaction without further purification; IR (KBr) νmax: 1784.17 cm -1 (-C=O, acid chloride). 58 was prepared from 3-thiophen-2-yl-propionic acid (10 mmol) and was used immediately in the subsequent reaction without further purification (pale yellow oil, 90.9% yield); IR (KBr) νmax: 1782.84 cm -1 (-C=O, acid chloride)
2-Phenylpropionyl chloride (6a)
3-Thiophen-2-yl-propionyl chloride (6b)
General method for imine formation
The appropriate amine (10 mmol) was heated at reflux with the appropriate aldehyde (10 mmol) in ethanol (50 mL) for 3 hours. The reaction mixture was reduced in vacuo and the resulting solution was left to stand until solid product crystallised. The resulting imine was recrystallised from ethanol. 6.1 N-(4-Methoxybenzylidene) C19H21NO5Na requires 366.1317.
3.1.
General method I for β-lactam preparation:
The appropriate imine (5 mmol) and triethylamine (15 mmol) were added to dry CH2Cl2 (50 mL) and the mixture was brought to reflux at 60°C. Once refluxing, the appropriately substituted acid chloride (7.5 mmol) was injected dropwise through a rubber stopper. This mixture was refluxed for 3 hours. The mixture was washed firstly with distilled water (50 mL) (twice) and then with saturated aqueous sodium bicarbonate solution (50 mL).
The organic layer was dried by filtration through anhydrous sodium sulfate. The organic layer containing the product was reduced in vacuo. The pure product was isolated by flash column chromatography over silica gel (hexane: ethyl acetate gradient). (m, 3H, ArH); 13 8.9 1-(3,4,5 
3-Cyclohexyl-4-(4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)azetidin-2-one (10)
General method II for β-lactam preparation:
The appropriate imine (10 mmol) and acetyl chloride (10 mmol) were added to CH2Cl2 (50 mL) under nitrogen and the mixture was left stirring for 2 hours. Triethylamine (10 mmol) was added dropwise. The mixture was left to stir overnight. The mixture was washed firstly with distilled water (50 mL) (twice) and then with saturated aqueous sodium bicarbonate solution (50 mL). The organic layer was dried by filtration through anhydrous sodium sulfate. The organic layer containing the product was collected and reduced in vacuo. The pure product was isolated by flash column chromatography over silica gel (hexane: ethyl acetate gradient). -1-(3,4,5-trimethoxyphenyl) 1.10.1 4-(4-Methoxyphenyl)-3-naphthalen-1-yl-1-(3,4,5-trimethoxyphenyl) 1.10.2 4-(4-Methoxyphenyl)-3-naphthalen-2-yl-1-(3,4,5-trimethoxyphenyl) 1.10.4 3-Furan-3-yl-4-(4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl) azetidin-2-one (23) was obtained from 2-(furan-3-yl)acetic acid and N-(4-methoxybenzylidene)-3,4,5-trimethoxybenzenamine 5 4-(4-Methoxyphenyl)-3-thiophen-3-yl-1-(3,4,5-trimethoxyphenyl) 1.10.7 3-Benzo[b]thiophen-2-yl-4-(4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl) 
4-(4-Methoxy-3-nitrophenyl)-3-thiophen-2-yl
General method IV for preparation of β-lactams 28 -29:
To a solution of the appropriately protected phenol (10 mmol) in THF (50 mL) was added 1.5 equivalents of 1M tetrabutylammonium fluoride. The solution was stirred in an ice-bath for 15 minutes. The reaction mixture was diluted with ethyl acetate (100 mL) and quenched with 10% HCl (100 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate (2 x 50 mL). The organic layer was then washed with water (100 mL) and brine (100 mL) and was dried with sodium sulphate. The pure product was isolated by flash column chromatography over silica gel (hexane: ethyl acetate gradient). 11.1 4-(3-Hydroxy-4-methoxyphenyl)-3-thiophen-2-yl-1-(3,4,5-trimethoxyphenyl) 1.11.2 4-(3-Hydroxy-4-methoxyphenyl)-3-thiophen-3-yl-1-(3,4,5-trimethoxyphenyl) reading the absorbance. The absorbance value of control cells (no added compound) was set to 100 % cell viability and from this graphs of absorbance versus cell density per well were prepared to assess cell viability using GraphPad Prism software 59 .
3.1.
Cytotoxicity assay using murine mammary epithelial cells
Mammary glands from 14-18 day pregnant CD-1 mice were used as source and primary mammary epithelial cell cultures were prepared from these. Mammary epithelial cells were isolated as described by us previously. 24 The isolated mammary epithelial cells were seeded at two concentrations. After 24 hours, they were treated with 2 µL volumes of test compound which had been pre-prepared as stock solutions in ethanol to furnish the concentration range of study, 1 nM-100 µM, and re-incubated for a further 72 h. Control wells contained the equivalent volume of the vehicle ethanol (1% v/v). The cytotoxicity was assessed using alamar blue dye as reported previously. 60
Tubulin polymerization:
Tubulin polymerisation was carried out using a kit supplied by Cytoskeleton. It is based on the principal that light is scattered by microtubules to an extent that is proportional to the concentration of the microtubule polymer. Compounds that interact with tubulin will alter the polymerisation of tubulin, and this can be detected using a spectrophotometer. The absorbance at 340nm at 37°C is monitored. The experimental procedure of the assay was performed as described in version 8.2 of the tubulin polymerisation assay kit manual 61 . 
Stability studies for
Figure 5. Cell viability in healthy murine epithelial cells
Mouse mammary epithelial cells were harvested from mid-to late-pregnant CD-1 mice and cultured.
The isolated mammary epithelial cells were seeded at two concentrations. After 24 hours, they were treated with 2 µL volumes of test compound which had been pre-prepared as stock solutions in ethanol to furnish the concentration range of study, 1 nM-100 µM, and re-incubated for a further 72 h. Control wells contained the equivalent volume of the vehicle ethanol (1% v/v). The cytotoxicity was assessed using alamar blue dye. b The IC50 value obtained for 2a in this assay is 0.0052 µM for MCF-7 which is in good agreement with the reported values for 2a using the MTT assay on human MCF-7 breast cancer cell line 18, 47, 48, 67 
